Clinical Management and Risk of Amputation among Patients with Critical Lower Limb Ischemia

被引:0
作者
Ciocan, R. A. [1 ]
Bolboaca, S. D. [2 ]
Drugan, T. C. [2 ]
Radulescu, S. [3 ]
Gherman, C. D. [3 ]
机构
[1] Emergency Cty Hosp Cluj Napoca, Dept Vasc Surg, Cluj Napoca, Romania
[2] Iuliu Hatieganu Univ Med & Pharm Cluj Napoca, Dept Med Informat & Biostat, Cluj Napoca, Romania
[3] Iuliu Hatieganu Univ Med & Pharm Cluj Napoca, Dept Surg 2, Cluj Napoca, Romania
来源
PROCEEDINGS OF THE 49TH ANNUAL SCIENTIFIC MEETING OF THE EUROPEAN SOCIETY FOR CLINICAL INVESTIGATION | 2015年
关键词
critical limb ischemia (CLI); patient care management; risk factor; amputation; PERIPHERAL ARTERIAL-DISEASE; PREVALENCE;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Our study aimed to analyze the clinical management of patients admitted with critical limb ischemia (CLI) at Second Surgical Clinic, Emergency County Hospital Cluj-Napoca and to identify the risk factors for amputation. Materials and methods: A three years retrospective study was conducted on subjects hospitalized for critical lower limb ischemia at Second Surgical Clinic, Emergency County Hospital Cluj-Napoca. The medical charts of patients with critical lower limb ischemia as principal diagnosis were reviewed and data were collected. Results: Four hundred and forty one patients with mean age of 66.22+/-10.40 years were included in the study. A significantly higher percentage of patients were male (M:F=4.25, p<0.0001). Smoking was positive on 67.12% of subject with significant higher percentage among men compared to women (76.75% vs. 26.19%, p<0.0001). Diabetes (F vs. M: 47.62% vs. 31.37%) and presence of ischemic heart disease (F vs. M: 64.29% vs. 47.34%) proved significantly more frequent in women compared to men (p<0.01). Ninety-nine bypasses were performed on the investigated sample (22.45%, 95% CI [18.59-26.76], values in square brackets are 95% confidence interval lower and upper bounds). Furthermore, more than half bypasses were at femuro-popliteal level (62.63% [52.53-71.71]). Other interventions included lumbar sympathectomy (1.81%), disarticulation (12.24%), amputation (17.01%) or soft tissues necrectomy (17.46%). Most patients received vasodilator (91.38%) and respectively anticoagulant (67.57%) treatment. Sepsis (5.22% [3.40-7.71]), bypass thrombosis (3.17% [1.81-5.44]), and lower limb haemorrhage (0.45% [0.00-1.81]) were the main complications. Favourable discharged status was observed on 85.26% of cases. Smoking proved a significant risk factors for amputation (OR=1.98 [1.06-3.70]). Conclusions: Bypass was the most frequent treatment strategy, with small percentage of complications while medical treatment included vasodilator and anticoagulant drugs. Smoking proved a significant risk factor for amputation.
引用
收藏
页码:113 / 118
页数:6
相关论文
共 19 条
  • [1] Bell P.R.F., 1992, SURG MANAGEMENT VASC, P519
  • [2] Impact of obesity control on circulating level of endothelial progenitor cells and angiogenesis in response to ischemic stimulation
    Chen, Yung-Lung
    Chang, Chia-Lo
    Sun, Cheuk-Kwan
    Wu, Chiung-Jen
    Tsai, Tzu-Hsien
    Chung, Sheng-Ying
    Chua, Sarah
    Yeh, Kuo-Ho
    Leu, Steve
    Sheu, Jiunn-Jye
    Lee, Fan-Yen
    Yen, Chia-Hung
    Yip, Hon-Kan
    [J]. JOURNAL OF TRANSLATIONAL MEDICINE, 2012, 10
  • [3] Cosmi B., 2001, COCHRANE DB SYST REV, V3
  • [4] dos Santos P.V., 2013, J VASC BRAS, V12
  • [5] Elsadig S.A., 2009, KHARTOUM MED J, V2, P172
  • [6] Eskelinen E., 2005, THESIS
  • [7] EDINBURGH ARTERY STUDY - PREVALENCE OF ASYMPTOMATIC AND SYMPTOMATIC PERIPHERAL ARTERIAL-DISEASE IN THE GENERAL-POPULATION
    FOWKES, FGR
    HOUSLEY, E
    CAWOOD, EHH
    MACINTYRE, CCA
    RUCKLEY, CV
    PRESCOTT, RJ
    [J]. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 1991, 20 (02) : 384 - 392
  • [8] Goldman L., 2012, TRANSLATION ROMANIAN, P486
  • [9] Exact Probabilities and Confidence Limits for Binomial Samples: Applied to the Difference between Two Proportions
    Jantschi, Lorentz
    Bolboaca, Sorana D.
    [J]. THESCIENTIFICWORLDJOURNAL, 2010, 10 : 865 - 878
  • [10] Mangiafico RA, 2011, CURR VASC PHARMACOL, V9, P658